<DOC>
	<DOCNO>NCT00676676</DOCNO>
	<brief_summary>The purpose study determine whether add low dose testosterone current antidepressant therapy improve depression fatigue woman remain depressed despite necessary adequate dos anti-depressants . Testosterone give 8-week period . Testosterone hormone occur naturally body . In woman come ovary adrenal gland find amount ten twenty time low men . In early research study , testosterone show antidepressant effect follow group subject : - Women anorexia nervosa - Women low testosterone level pituitary gland work - Men Selective Serotonin Reuptake Inhibitor ( SSRI ) -resistant depression . However , testosterone administration woman SSRI Serotonin-norepinephrine reuptake inhibitor ( SNRI ) -resistant depression study .</brief_summary>
	<brief_title>Effects Testosterone Women With Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Female , age 1875 Written inform consent Meet Diagnostic Statistical Manual Mental Disorders , 4th edition ( DSMIV ) criterion ( Structured Clinical Interview DSMIV ( SCID ) ) Major Depressive Disorder Meet DSMIV criterion current major depressive episode , assess SCID MontgomeryAsberg Depression Rating Scale ( MADRS ) great equal 16 baseline visit Currently treat SSRI SNRI , without adjunctive therapy , adequate dose ( see adequate dose table ) least six week Pregnant woman woman child bear potential use medically accept mean contraception ( include oral contraceptive implant , condom , diaphragm , spermicide , intrauterine device , tubal ligation , partner vasectomy ) Serious suicide homicide risk , assess evaluate clinician Unstable medical illness include cardiovascular , hepatic , renal , respiratory , endocrine , neurologic ( include uncontrolled seizure disorder ) Substance use disorder active within last six month Psychotic feature ( current episode lifetime ) , assess SCID Laboratory evidence untreated hypothyroidism If treat hypothyroidism , significant change levothyroxine dose within prior three month If receive oral estrogen therapy , include oral contraceptive transdermal estrogen therapy , significant change dose prior three month Use androgens androgen precursor , include testosterone , Dehydroepiandrosterone ( DHEA ) methyltestosterone , within prior three month Any investigational psychotropic drug within last two week In judgment study clinician , unlikely able participate safely throughout study period ( three episode selfharm past year , document history poor treatment adherence , frequent miss appointment ( great 50 % ) past year ) Alanine aminotransferase ( ALT ) great 1.5 time upper limit normal . Creatinine great 1.5 time upper limit normal History hormoneresponsive cancer History congestive heart failure MADRS great 31</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Depression</keyword>
	<keyword>Major Depressive Disorder</keyword>
</DOC>